↓ Skip to main content

Depot fluspirilene for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2007
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
4 X users
weibo
1 weibo user
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
142 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Depot fluspirilene for schizophrenia
Published in
Cochrane database of systematic reviews, January 2007
DOI 10.1002/14651858.cd001718.pub2
Pubmed ID
Authors

Akhil Abhijnhan, Clive E Adams, Anthony David, Mehmet Ozbilen

Abstract

Antipsychotic drugs are the mainstay treatment for schizophrenia and similar psychotic disorders. Long-acting depot injections of drugs such as fluspirilene are extensively used as a means of long-term maintenance treatment.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 142 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 141 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 22 15%
Student > Master 20 14%
Researcher 15 11%
Student > Ph. D. Student 13 9%
Student > Doctoral Student 7 5%
Other 27 19%
Unknown 38 27%
Readers by discipline Count As %
Medicine and Dentistry 39 27%
Psychology 19 13%
Nursing and Health Professions 11 8%
Chemistry 5 4%
Social Sciences 4 3%
Other 23 16%
Unknown 41 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2023.
All research outputs
#6,531,102
of 25,483,400 outputs
Outputs from Cochrane database of systematic reviews
#8,245
of 13,137 outputs
Outputs of similar age
#36,218
of 174,081 outputs
Outputs of similar age from Cochrane database of systematic reviews
#35
of 71 outputs
Altmetric has tracked 25,483,400 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 13,137 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,081 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.